UNITED THERAPEUTICS Corp ($UTHR)
Filing Information
| Accession Number | 0001673232-26-000007 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 28, 2026 |
| Document Date | Jan 20, 2026 |
| Document | View SEC Filing |
Transactions
22
Total Shares
91,125
Total Value
$18,299,326.40
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PRESIDENT AND COO | Common Stock | โ | Jan 20, 2026 | Exercise/Conversion | 7,875 | $146.03 | $1,149,986.25 | 7,875 | Indirect | by Trust | View Details | |
PRESIDENT AND COO | Common Stock | โ | Jan 20, 2026 | Sale | 63 | $456.87 | $28,782.51 | 7,812 | Indirect | by Trust | View Details | |
PRESIDENT AND COO | Common Stock | โ | Jan 20, 2026 | Sale | 372 | $457.92 | $170,345.50 | 7,440 | Indirect | by Trust | View Details | |
PRESIDENT AND COO | Common Stock | โ | Jan 20, 2026 | Sale | 377 | $458.74 | $172,943.55 | 7,063 | Indirect | by Trust | View Details | |
PRESIDENT AND COO | Common Stock | โ | Jan 20, 2026 | Sale | 268 | $459.86 | $123,243.74 | 6,795 | Indirect | by Trust | View Details | |
PRESIDENT AND COO | Common Stock | โ | Jan 20, 2026 | Sale | 271 | $461.12 | $124,963.06 | 6,524 | Indirect | by Trust | View Details | |
PRESIDENT AND COO | Common Stock | โ | Jan 20, 2026 | Sale | 1,322 | $463.26 | $612,430.25 | 5,202 | Indirect | by Trust | View Details | |
PRESIDENT AND COO | Common Stock | โ | Jan 20, 2026 | Sale | 1,225 | $464.06 | $568,468.48 | 3,977 | Indirect | by Trust | View Details | |
PRESIDENT AND COO | Common Stock | โ | Jan 20, 2026 | Sale | 966 | $465.11 | $449,295.78 | 3,011 | Indirect | by Trust | View Details | |
PRESIDENT AND COO | Common Stock | โ | Jan 20, 2026 | Sale | 568 | $466.06 | $264,723.84 | 2,443 | Indirect | by Trust | View Details | |
PRESIDENT AND COO | Common Stock | โ | Jan 20, 2026 | Sale | 321 | $467.09 | $149,936.28 | 2,122 | Indirect | by Trust | View Details | |
PRESIDENT AND COO | Common Stock | โ | Jan 20, 2026 | Sale | 1,573 | $468.12 | $736,346.94 | 549 | Indirect | by Trust | View Details | |
PRESIDENT AND COO | Common Stock | โ | Jan 20, 2026 | Sale | 451 | $469.18 | $211,600.09 | 98 | Indirect | by Trust | View Details | |
PRESIDENT AND COO | Common Stock | โ | Jan 20, 2026 | Sale | 84 | $470.37 | $39,511.08 | 14 | Indirect | by Trust | View Details | |
PRESIDENT AND COO | Common Stock | โ | Jan 20, 2026 | Sale | 14 | $470.75 | $6,590.57 | 0 | Indirect | by Trust | View Details | |
PRESIDENT AND COO | Common Stock | โ | Jan 26, 2026 | Exercise/Conversion | 14,625 | $117.76 | $1,722,240.00 | 14,625 | Indirect | by Trust | View Details | |
PRESIDENT AND COO | Common Stock | โ | Jan 26, 2026 | Sale | 14,625 | $471.91 | $6,901,655.96 | 0 | Indirect | by Trust | View Details | |
PRESIDENT AND COO | Common Stock | โ | Jan 26, 2026 | Exercise/Conversion | 7,875 | $146.03 | $1,149,986.25 | 7,875 | Indirect | by Trust | View Details | |
PRESIDENT AND COO | Common Stock | โ | Jan 26, 2026 | Sale | 7,875 | $471.91 | $3,716,276.29 | 0 | Indirect | by Trust | View Details | |
PRESIDENT AND COO | Stock Options | Derivative | Jan 20, 2026 | Exercise/Conversion | 7,875 | $0.00 | $0.00 | 36,565 | Indirect | by Trust | View Details | |
PRESIDENT AND COO | Stock Options | Derivative | Jan 26, 2026 | Exercise/Conversion | 14,625 | $0.00 | $0.00 | 53,250 | Indirect | by Trust | View Details | |
PRESIDENT AND COO | Stock Options | Derivative | Jan 26, 2026 | Exercise/Conversion | 7,875 | $0.00 | $0.00 | 28,690 | Indirect | by Trust | View Details |